Libya faces Prograph drug shortage for kidney patients

Libya is facing a severe crisis in the supply of the immunosuppressant drug "Prograph" for kidney and liver transplant patients. The medication has been unavailable for approximately four months, putting the lives of more than 2,200 patients at risk. The head of the "National Organization for Supporting Organ Donation" confirmed that the annual cost to provide the medication, which does not exceed 9.5 million euros, could meet the needs, emphasizing the urgent need for intervention by the relevant authorities. The organization reaffirms its calls for the import of the drugs and the cessation of deaths resulting from the lack of treatment.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article